CNBC - Healthcare

Jim Cramer identified two of his favorite stocks to buy and the names he's not willing to touch just yet.

His comments come after Merck officially opened its new 120,000-square-foot research facility in the Greater Philadelphia area.

Kate Ryder's Maven has AI writing all of its code and the CEO sees huge promise for the tech in women's healthcare. But there's one thing she won't cede to AI.

Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

UnitedHealth Group said it expects 2026 adjusted earnings of at least $20.50 per share, up from a previous outlook of $19.50 to $20.00 per share.